CTLA-4 gene polymorphism in promoter and exon-1 regions in Chinese patients with systemic lupus erythematosus
Authors:
- M-F LiuMLM-F Liu
- C-R WangCWC-R Wang
- L-C LinLLL-C Lin
- 1 September 2001
- journal article
- research article
- Published by SAGE Publications in Lupus
- Vol. 10 (9) , 647-649
Abstract
Cytotoxic T lymphocyte associated antigen 4 (CTLA-4), a structural homologue of CD28, has been reported to be an important negative regulator of autoimmune diseases. Recent studies showed that CTLA-4 gene polymorphism was associated with several kinds of human autoimmune diseases, suggesting that CTLA-4 gene is probably a general susceptibility gene to autoimmune disease. The present study was conducted in Chinese to determine whether there is any association of the CTLA-4 gene polymorphism with the development of systemic lupus erythematosus (SLE). CTLA-4 gene polymorphism in promoter and exon 1 was detected by polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP) method in 81 patients with SLE and 81 normal controls. The results showed that there were no statistically significant differences in both exon 1 and promoter gene polymorphism between SLE patients and normal controls. The preliminary study does not suggest an association of the known polymorphism in exon 1 and promoter of CTLA-4 gene with Chinese SLE. However, SLE is a very heterogeneous syndrome and CTLA-4 gene polymorphism might correlate with some specific clinical features. To exploring this possibility, subgroup analysis in more patients needs to be performed.Keywords
This publication has 17 references indexed in Scilit:
- CTLA-4 Gene Polymorphism at Position 49 in Exon 1 Reduces the Inhibitory Function of CTLA-4 and Contributes to the Pathogenesis of Graves’ DiseaseThe Journal of Immunology, 2000
- CTLA-4 in autoimmune diseases – a general susceptibility gene to autoimmunity?Genes & Immunity, 2000
- The A-G polymorphism in exon 1 of theCTLA-4 gene is not associated with systemic lupus erythematosusAnnals of the Rheumatic Diseases, 1999
- CTLA-4: a negative regulator of autoimmune disease.Journal of Experimental Medicine, 1996
- An Mse I RFLP in the Human CTLA4 PromotorBiochemical and Biophysical Research Communications, 1996
- The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes RegistryHuman Molecular Genetics, 1996
- CTLA-4 ligation blocks CD28-dependent T cell activation.Journal of Experimental Medicine, 1996
- CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells.Journal of Experimental Medicine, 1996
- CD28/B7 SYSTEM OF T CELL COSTIMULATIONAnnual Review of Immunology, 1996
- The 1982 revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1982